All bills
SR 4 The committee on HHS deferred the measure

REQUESTING THE AUDITOR TO ASSESS BOTH THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR A PERCENTAGE OF THE COSTS OF INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION.

Official Bill Page

Loading official bill page…

Legislative Timeline

4 actions
  1. Mar 24, 2025 upper
    The committee on HHS deferred the measure.
  2. Mar 20, 2025 upper
    The committee(s) on HHS has scheduled a public hearing on 03-24-25 1:05PM; Conference Room 225 & Videoconference.
  3. Feb 3, 2025 upper
    Referred to HHS, WAM.
  4. Jan 30, 2025 upper
    Offered.
About this civic dataset

About this legislation view

Track federal and state bills and legislation — browse by chamber, status, and day, with summaries and sponsor details, updated daily on Civic Stream.

Use the scope, chamber, status, and search controls to move from the national legislation picture down to an exact state or legislative stage.